Phosphorylation of Tau at S422 is enhanced by Aβ in TauPS2APP triple transgenic mice

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864 · see citing works

The Mouse Brain in Stereotaxic Coordinates

Paxinos, G. (2001) · Cited by 12,859 · see citing works

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659 · see citing works

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works

Triple-Transgenic Model of Alzheimer’s Disease with Plaques and Tangles

Oddo, S., Caccamo, A., Shepherd, J. D., Murphy, M. P., Golde, T. E., Kayed, R., Metherate, R., Mattson, M. P., Akbari, Y., & LaFerla, F. M. (2003) · Neuron · doi:10.1016/s0896-6273(03)00434-3 · Cited by 4,126 · see citing works

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051 · see citing works

Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17

Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · see citing works

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577 · see citing works

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516 · see citing works

Synapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model

Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208 · see citing works

Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP

Lewis, J., Dickson, D. W., Lin, W.-L., Chisholm, L., Corral, A., Jones, G., Yen, S.-H., Sahara, N., Skipper, L., Yager, D., et al. (2001) · Science · doi:10.1126/science.1058189 · Cited by 1,611 · see citing works

Magnetic resonance imaging of perfusion using spin inversion of arterial water.

Williams, D. S., Detre, J. A., Leigh, J. S., & Koretsky, A. P. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.1.212 · Cited by 1,553 · see citing works

Formation of Neurofibrillary Tangles in P301L Tau Transgenic Mice Induced by Aβ42 Fibrils

Götz, J., Chen, F., van Dorpe, J., & Nitsch, R. M. (2001) · Science · doi:10.1126/science.1062097 · Cited by 1,526 · see citing works

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507 · see citing works

Mutation in the tau gene in familial multiple system tauopathy with presenile dementia

Spillantini, M. G., Murrell, J. R., Goedert, M., Farlow, M. R., Klug, A., & Ghetti, B. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.13.7737 · Cited by 1,474 · see citing works

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386 · see citing works

Tau is a candidate gene for chromosome 17 frontotemporal dementia

Poorkaj, P., Bird, T. D., Wijsman, E., Nemens, E., Garruto, R. M., Anderson, L., Andreadis, A., Wiederholt, W. C., Raskind, M., & Schellenberg, G. D. (1998) · Annals of Neurology · doi:10.1002/ana.410430617 · Cited by 1,374 · see citing works

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

Lewis, J., McGowan, E., Rockwood, J., Melrose, H., Nacharaju, P., Van Slegtenhorst, M., Gwinn-Hardy, K., Murphy, M. P., Baker, M., Yu, X., et al. (2000) · Nature Genetics · doi:10.1038/78078 · Cited by 1,371 · see citing works

FLASH imaging: Rapid NMR imaging using low flip-angle pulses

Haase, A., Frahm, J., Matthaei, D., Hänicke, W., & Merboldt, K. D. (2011) · Journal of Magnetic Resonance · doi:10.1016/j.jmr.2011.09.021 · Cited by 1,153 · see citing works

New stereological methods for counting neurons

West, M. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90112-o · Cited by 940 · see citing works

FLASH imaging. Rapid NMR imaging using low flip-angle pulses

Haase, A., Frahm, J., Matthaei, D., Hänicke, W., & Merboldt, K. D. (1986) · Journal of Magnetic Resonance (1969) · doi:10.1016/0022-2364(86)90433-6 · Cited by 826 · see citing works

Reduced Transit-Time Sensitivity in Noninvasive Magnetic Resonance Imaging of Human Cerebral Blood Flow

Alsop, D. C., & Detre, J. A. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199611000-00019 · Cited by 754 · see citing works

Abundant Tau Filaments and Nonapoptotic Neurodegeneration in Transgenic Mice Expressing Human P301S Tau Protein

Allen, B., Ingram, E., Takao, M., Smith, M. J., Jakes, R., Virdee, K., Yoshida, H., Holzer, M., Craxton, M., Emson, P. C., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09340.2002 · Cited by 746 · see citing works

A preparation of Alzheimer paired helical filaments that displays distinct tau proteins by polyacrylamide gel electrophoresis.

Greenberg, S. G., & Davies, P. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5827 · Cited by 732 · see citing works

Animal models of Alzheimer's disease and frontotemporal dementia

Götz, J., & Ittner, L. M. (2008) · Nature Reviews Neuroscience · doi:10.1038/nrn2420 · Cited by 676 · see citing works

Pattern of Cerebral Hypoperfusion in Alzheimer Disease and Mild Cognitive Impairment Measured with Arterial Spin-labeling MR Imaging: Initial Experience

Johnson, N. A., Jahng, G., Weiner, M. W., Miller, B. L., Chui, H. C., Jagust, W. J., Gorno‐Tempini, M. L., & Schuff, N. W. (2005) · Radiology · doi:10.1148/radiol.2343040197 · Cited by 580 · see citing works

Positron emission tomography in Alzheimer's disease

Duara, R., Grady, C., Haxby, J. V., Sundaram, M., Cutler, N. R., Heston, L. L., Moore, A., Schlageter, N. L., Larson, S., & Рапопорт, С. И. (1986) · Neurology · doi:10.1212/wnl.36.7.879 · Cited by 568 · see citing works

Proline-directed and non-proline-directed phosphorylation of PHF-tau

Morishima-Kawashima, M., Hasegawa, M., Takio, K., Suzuki, M., Yoshida, H., Titani, K., & Ihara, Y. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.2.823 · Cited by 557 · see citing works

Tau filament formation in transgenic mice expressing P301L tau

Götz, J., Chen, F., Barmettler, R., & Nitsch, R. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006531200 · Cited by 495 · see citing works

Novel phosphorylation sites in tau from Alzheimer brain support a role for casein kinase 1 in disease pathogenesis

Hanger, D. P., Byers, H. L., Wray, S., Leung, K.-Y., Saxton, M. J., Seereeram, A., Reynolds, C. H., Ward, M. A., & Anderton, B. H. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703269200 · Cited by 455 · see citing works

Silver staining of Alzheimer's neurofibrillary changes by means of physical development.

Gallyas, F. (1971) · PubMed · Cited by 411 · see citing works

Axonopathy and amyotrophy in mice transgenic for human four-repeat tau protein

Probst, A., Götz, J., Wiederhold, K., Tolnay, M., Mistl, C., Jaton, A., Hong, M., Ishihara, T., Lee, V., Trojanowski, J., et al. (2000) · Acta Neuropathologica · doi:10.1007/s004010051148 · Cited by 362 · see citing works

Phosphorylation of microtubule‐associated protein tau by stress‐activated protein kinases

Goedert, M., Hasegawa, M., Jakes, R., Lawler, S., Cuenda, A., & Cohen, P. R. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)00483-3 · Cited by 308 · see citing works

Induction of Tau Pathology by Intracerebral Infusion of Amyloid-β-Containing Brain Extract and by Amyloid-β Deposition in APP × Tau Transgenic Mice

Bolmont, T., Clavaguera, F., Meyer-Luehmann, M., Herzig, M. C., Radde, R., Staufenbiel, M., Lewis, J., Hutton, M., Tolnay, M., & Jucker, M. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070403 · Cited by 281 · see citing works

Tau filament formation and associative memory deficit in aged mice expressing mutant (R406W) human tau

Tatebayashi, Y., Miyasaka, T., Chui, D., Akagi, T., Mishima, K., Iwasaki, K., Fujiwara, M., Tanemura, K., Murayama, M., Ishiguro, K., et al. (2002) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.202205599 · Cited by 279 · see citing works

Amyloid beta peptides and glutamatergic synaptic dysregulation

Parameshwaran, K., Dhanasekaran, M., & Suppiramaniam, V. D. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.10.008 · Cited by 232 · see citing works

FTDP-17 mutations in tau transgenic mice provoke lysosomal abnormalities and Tau filaments in forebrain.

Lim, F., Hernández, F., Lucas, J., Gómez-Ramos, P., Morán, M., & Ávila, J. (2001) · Molecular and cellular neurosciences · doi:10.1006/mcne.2001.1051 · Cited by 215 · see citing works

PS2APP Transgenic Mice, Coexpressing hPS2mut and hAPPswe, Show Age-Related Cognitive Deficits Associated with Discrete Brain Amyloid Deposition and Inflammation

Richards, J. G., Higgins, G. A., Ouagazzal, A., Ozmen, L., Kew, J. N. C., Bohrmann, B., Malherbe, P., Brockhaus, M., Loetscher, H., Czech, C., et al. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-26-08989.2003 · Cited by 200 · see citing works

Inability of tau to properly regulate neuronal microtubule dynamics: a loss-of-function mechanism by which tau might mediate neuronal cell death

Feinstein, S. C., & Wilson, L. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.07.002 · Cited by 191 · see citing works

β-Amyloid Induces Paired Helical Filament-like Tau Filaments in Tissue Culture

Ferrari, A., Hoerndli, F. J., Baechi, T., Nitsch, R. M., & Götz, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308243200 · Cited by 182 · see citing works

Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.

Ishihara, T., Zhang, B., Higuchi, M., Yoshiyama, Y., Trojanowski, J., & Lee, V. (2001) · American Journal of Pathology · doi:10.1016/s0002-9440(10)63997-1 · Cited by 178 · see citing works

Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice

Ribé, E. M., Pérez, M., Puig, B., Gich, I., Lim, F., Cuadrado, M., Sesma, T., Catena, S., Sánchez, B., Nieto, M., et al. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.05.027 · Cited by 162 · see citing works

Characterization of mAb AP422, a novel phosphorylation‐dependent monoclonal antibody against tau protein

Hasegawa, M., Jakes, R., Crowther, R. A., Lee, V. M.-Y., Ihara, Y., & Goedert, M. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00271-2 · Cited by 156 · see citing works

Presenilins Are Processed by Caspase-type Proteases

Loetscher, H., Deuschle, U., Brockhaus, M., Reinhardt, D., Nelboeck, P., Mous, J., Grünberg, J., Haass, C., & Jacobsen, H. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.33.20655 · Cited by 153 · see citing works

Assessing the effects of the 129/Sv genetic background on swimming navigation learning in transgenic mutants: a study using mice with a modified β-amyloid precursor protein gene

Wolfer, D. P., Müller, U., Stagljar, M., & Lipp, H. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00673-2 · Cited by 124 · see citing works

Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration

Bussière, T., Hof, P. R., Vanbesien-Mailliot, C., Brown, C., Caillet‐Boudin, M., Perl, D. P., Buée, L., & Delacourte, A. (1999) · Acta Neuropathologica · doi:10.1007/s004010050978 · Cited by 102 · see citing works

Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice

Pennanen, L., Wolfer, D. P., Nitsch, R. M., & Götz, J. (2005) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2005.00165.x · Cited by 102 · see citing works

Expression of Transgenic APP mRNA Is the Key Determinant for Beta-Amyloid Deposition in PS2APP Transgenic Mice

Ozmen, L., Albientz, A., Czech, C., & Jacobsen, H. (2008) · Neurodegenerative Diseases · doi:10.1159/000170884 · Cited by 95 · see citing works

Coinjection strategy for visual identification of transgenic mice

Overbeek, P. A., Aguilar-Córdova, E., Hanten, G. R., Schaffner, D. L., Patel, P., Lebovitz, R. M., & Lieberman, M. W. (1991) · Transgenic Research · doi:10.1007/bf02512994 · Cited by 93 · see citing works

Divergent phosphorylation pattern of tau in P301L tau transgenic mice

Deters, N. A., Ittner, L. M., & Götz, J. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06318.x · Cited by 89 · see citing works

Characterisation of cytoskeletal abnormalities in mice transgenic for wild-type human tau and familial Alzheimer's disease mutants of APP and presenilin-1

Boutajangout, A., Authelet, M., Blanchard, V., Touchet, N., Tremp, G. L., Pradier, L., & Brion, J. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.09.007 · Cited by 88 · see citing works

Characterization of a double (amyloid precursor protein-tau) transgenic: Tau phosphorylation and aggregation

Pérez, M., Ribé, E. M., Rubio, A., Lim, F., Morán, M. A., Gómez‐Ramos, P., Ferrer, I., Isla, M. T. G., & Ávila, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.029 · Cited by 83 · see citing works

Genetically augmenting tau levels does not modulate the onset or progression of Aβ pathology in transgenic mice

Oddo, S., Caccamo, A., Cheng, D., Jouleh, B., Torp, R., & LaFerla, F. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04607.x · Cited by 78 · see citing works

Influence of the selective ORL1 receptor agonist, Ro64-6198, on rodent neurological function

Higgins, G. A., Grottick, A. J., Ballard, T. M., Richards, J. G., Messer, J., Takeshima, H., Pauly-Evers, M., Jenck, F., Adam, G., & Wichmann, J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(01)00048-x · Cited by 71 · see citing works

Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: comprehensive phenotyping of vascular and tissular parameters by MRI

Weidensteiner, C., Metzger, F., Bohrmann, A. B. B., Kuennecke, B., & von Kienlin, M. (2009) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21985 · Cited by 56 · see citing works

Distribution and abundance of metabotropic glutamate receptor subtype 2 in rat brain revealed by [3H]LY354740 binding in vitro and quantitative radioautography: Correlation with the sites of synthesis, expression, and agonist stimulation of [35S]GTPγs binding

Richards, G. J., Messer, J., Malherbe, P., Pink, R., Brockhaus, M., Stadler, H., Wichmann, J., Schaffhauser, H., & Mutel, V. (2005) · The Journal of Comparative Neurology · doi:10.1002/cne.20538 · Cited by 53 · see citing works

Rapid cellular uptake of Alzheimer amyloid βA4 peptide by cultured human neuroblastoma cells

Ida, N., Masters, C. L., & Beyreuther, K. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00948-9 · Cited by 50 · see citing works

Different tau epitopes define Aβ42-mediated tau insolubility

Pennanen, L., & Götz, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.168 · Cited by 31 · see citing works

Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer’s disease

Woodhouse, A., Shepherd, C. E., Sokolova, A., Carroll, V. L., King, A. E., Halliday, G. M., Dickson, T. C., & Vickers, J. C. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0458-z · Cited by 29 · see citing works

Cholesterol independent effect of LXR agonist TO‐901317 on gamma‐secretase

Czech, C., Burns, M. P., Vardanian, L., Augustin, A., Jacobsen, H., Baumann, K., & Rebeck, G. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04467.x · Cited by 27 · see citing works

Thermodynamic Studies on the Interaction of Antibodies with β-Amyloid Peptide

Brockhaus, M., Ganz, P., Huber, W., Bohrmann, B., Loetscher, H., & Seelig, J. (2007) · The Journal of Physical Chemistry B · doi:10.1021/jp0664059 · Cited by 24 · see citing works

BACE/APPV717F Double-Transgenic Mice Develop Cerebral Amyloidosis and Inflammation

Ozmen, L., Woolley, M. L., Albientz, A., Miss, M.-T., Nelboeck, P., Malherbe, P., Czech, C., Grüninger-Leitch, F., Brockhaus, M., Ballard, T. M., et al. (2005) · Neurodegenerative Diseases · doi:10.1159/000092314 · Cited by 11 · see citing works

Opposite effects of Zn on the in vitro binding of [3H]LY354740 to recombinant and native metabotropic glutamate 2 and 3 receptors

Malherbe, P., Richards, J. G., Broger, C., Zenner, M., Messer, J., Kratzeisen, C., Nakanishi, S., & Mutel, V. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03176.x · Cited by 9 · see citing works

Untitled work

Jones (1999) · doi:10.1002/(sici)1522-2594(199907)42:1

Amyloid-β and tau — a toxic pas de deux in Alzheimer's disease

Ittner, L. M., & Götz, J. (2010) · Nature reviews. Neuroscience · doi:10.1038/nrn2967 · Cited by 1,357 · see citing works

Alzheimer's disease: experimental models and reality

Drummond, E., & Wisniewski, T. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1662-x · Cited by 810 · see citing works

Amyloid-β and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice

Rhein, V., Song, X., Wiesner, A., Ittner, L. M., Baysang, G., Meier, F., Ozmen, L., Bluethmann, H., Dröse, S., Brandt, U., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905529106 · Cited by 655 · see citing works

Tau Aggregation and Its Interplay with Amyloid-β

Nisbet, R. M., Polanco, J.-C., Ittner, L. M., & Götz, J. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1371-2 · Cited by 359 · see citing works

Chaperone-mediated autophagy prevents collapse of the neuronal metastable proteome

Bourdenx, M., Martín-Segura, A., Scrivo, A., Rodriguez-Navarro, J. A., Kaushik, S., Tasset, I., Diaz, A., Storm, N. J., Xin, Q., Juste, Y. R., et al. (2021) · Cell · doi:10.1016/j.cell.2021.03.048 · Cited by 337 · see citing works

Abnormal tau, mitochondrial dysfunction, impaired axonal transport of mitochondria, and synaptic deprivation in Alzheimer's disease

Reddy, P. H. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.052 · Cited by 300 · see citing works

Amyloid β, Tau, and α-Synuclein aggregates in the pathogenesis, prognosis, and therapeutics for neurodegenerative diseases

Sengupta, U., & Kayed, R. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102270 · Cited by 303 · see citing works

Trem2 restrains the enhancement of tau accumulation and neurodegeneration by β-amyloid pathology

Lee, S.-H., Meilandt, W. J., Xie, L., Gandham, V. D., Ngu, H., Barck, K. H., Rezzonico, M. G., Imperio, J., Lalehzadeh, G., Huntley, M. A., et al. (2021) · Neuron · doi:10.1016/j.neuron.2021.02.010 · Cited by 300 · see citing works

Protein phosphorylation in neurodegeneration: friend or foe?

Tenreiro, S., Eckermann, K., & Outeiro, T. F. (2014) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2014.00042 · Cited by 252 · see citing works

MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease

Balusu, S., Horré, K., Thrupp, N., Craessaerts, K., Snellinx, A., Serneels, L., T’Syen, D., Chrysidou, I., Arranz, A. M., Sierksma, A. S. R., et al. (2023) · Science · doi:10.1126/science.abp9556 · Cited by 234 · see citing works

Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in a mouse model of Alzheimer’s disease

Zeng, H., Huang, J., Zhou, H., Meilandt, W. J., Dejanovic, B., Zhou, Y., Bohlen, C. J., Lee, S.-H., Ren, J., Liu, A., et al. (2023) · Nature Neuroscience · doi:10.1038/s41593-022-01251-x · Cited by 157 · see citing works

Disease-associated oligodendrocyte responses across neurodegenerative diseases

Pandey, S., Shen, K., Lee, S.-H., Shen, Y.-A. A., Wang, Y., Otero-García, M., Kotova, N., Vito, S. T., Laufer, B. I., Newton, D. F., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111189 · Cited by 227 · see citing works

Neuronal uptake of tau/pS422 antibody and reduced progression of tau pathology in a mouse model of Alzheimer‘s disease

Collin, L., Bohrmann, B., Göpfert, U., Oroszlan‐Szovik, K., Ozmen, L., & Grüninger, F. (2014) · Brain · doi:10.1093/brain/awu213 · Cited by 203 · see citing works

Lack of Widespread BBB Disruption in Alzheimer’s Disease Models: Focus on Therapeutic Antibodies

Bien-Ly, N., Boswell, C. A., Jeet, S., Beach, T. G., Hoyte, K., Luk, W., Shihadeh, V., Ulufatu, S., Foreman, O., Lu, Y., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.09.036 · Cited by 198 · see citing works

Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach

Zommer, N., Sergeant, N., Schraen-Maschke, S., Blum, D., & Buee, L. (2012) · Current Alzheimer Research · doi:10.2174/156720512800492503 · Cited by 193 · see citing works

Convergence of Amyloid-β and Tau Pathologies on Mitochondria In Vivo

Eckert, A., Schulz, K. L., Rhein, V. F., & Götz, J. (2010) · Molecular Neurobiology · doi:10.1007/s12035-010-8109-5 · Cited by 158 · see citing works

Amyloid-β42/40 ratio drives tau pathology in 3D human neural cell culture models of Alzheimer’s disease

Kwak, S. S., Washicosky, K. J., Brand, E., von Maydell, D., Aronson, J., Kim, S., Capen, D. E., Cetinbas, M., Sadreyev, R., Ning, S., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15120-3 · Cited by 151 · see citing works

JNK Plays a Key Role in Tau Hyperphosphorylation in Alzheimer's Disease Models

Ploia, C., Antoniou, X., Sclip, A., Grande, V., Cardinetti, D., Colombo, A., Canu, N., Benussi, L., Ghidoni, R., Forloni, G., et al. (2011) · Journal of Alzheimer's Disease · doi:10.3233/jad-2011-110320 · Cited by 145 · see citing works

Insights into Mitochondrial Dysfunction: Aging, Amyloid-β, and Tau–A Deleterious Trio

Schmitt, K., Grimm, A., Wilkaniec, A., Strosznajder, J. B., Götz, J., & Eckert, A. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4400 · Cited by 132 · see citing works

Region-specific permeability of the blood–brain barrier upon pericyte loss

Villaseñor, R., Künnecke, B., Ozmen, L., Ammann, M., Kugler, C., Grüninger, F., Loetscher, H., Freskgård, P., & Collin, L. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17697340 · Cited by 133 · see citing works

Expression of A152T human tau causes age‐dependent neuronal dysfunction and loss in transgenic mice

Maeda, S., Djukic, B., Taneja, P., Yu, G.-Q., Lo, I., Davis, A., Craft, R., Guo, W., Wang, X., Kim, D., et al. (2016) · EMBO Reports · doi:10.15252/embr.201541438 · Cited by 130 · see citing works

Alzheimer’s disease: Ablating single master site abolishes tau hyperphosphorylation

Stefanoska, K., Gajwani, M., Tan, A. R. P., Ahel, H. I., Asih, P. R., Volkerling, A., Poljak, A., & Ittner, A. (2022) · Science Advances · doi:10.1126/sciadv.abl8809 · Cited by 128 · see citing works

Neuron Loss in Transgenic Mouse Models of Alzheimer's Disease

Wirths, O., & Bayer, T. A. (2010) · International Journal of Alzheimer s Disease · doi:10.4061/2010/723782 · Cited by 110 · see citing works

Targeting Synaptic Plasticity in Experimental Models of Alzheimer’s Disease

Mango, D., Saidi, A., Cisale, G. Y., Feligioni, M., Corbo, M., & Nisticò, R. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00778 · Cited by 109 · see citing works

Alzheimer, mitochondria and gender

Grimm, A., Mensah‐Nyagan, A. G., & Eckert, A. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.04.012 · Cited by 107 · see citing works

A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain

Ercan-Herbst, E., Ehrig, J., Schöndorf, D. C., Behrendt, A., Klaus, B., Gomez Ramos, B., Prat Oriol, N., Weber, C., & Ehrnhoefer, D. E. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0823-2 · Cited by 101 · see citing works

Targeting Synaptic Dysfunction in Alzheimer’s Disease Therapy

Nisticò, R., Pignatelli, M., Piccinin, S., Mercuri, N. B., & Collingridge, G. L. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8324-3 · Cited by 97 · see citing works

Invited review: Animal models of tauopathies and their implications for research/translation into the clinic

Dujardin, S., Colin, M., & Buée, L. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12200 · Cited by 88 · see citing works

What Renders TAU Toxic

Götz, J., Xia, D., Leinenga, G., Chew, Y. L., & Nicholas, H. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00072 · Cited by 85 · see citing works

Trafficking of Endogenous Immunoglobulins by Endothelial Cells at the Blood-Brain Barrier

Villaseñor, R., Ozmen, L., Messaddeq, N., Grüninger, F., Loetscher, H., Keller, A., Betsholtz, C., Freskgård, P., & Collin, L. (2016) · Scientific Reports · doi:10.1038/srep25658 · Cited by 84 · see citing works

Modes of Aβ toxicity in Alzheimer’s disease

Götz, J., Eckert, A., Matamales, M., Ittner, L. M., & Liu, X. (2011) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-011-0750-2 · Cited by 84 · see citing works

Tau‐targeting passive immunization modulates aspects of pathology in tau transgenic mice

Ittner, A., Bertz, J., Suh, L. S., Stevens, C. H., Götz, J., & Ittner, L. M. (2014) · Journal of Neurochemistry · doi:10.1111/jnc.12821 · Cited by 81 · see citing works

Alzheimer's Disease and Amyloid: Culprit or Coincidence?

Skaper, S. D. (2012) · International review of neurobiology · doi:10.1016/b978-0-12-386986-9.00011-9 · Cited by 80 · see citing works

TREM2-independent oligodendrocyte, astrocyte, and T cell responses to tau and amyloid pathology in mouse models of Alzheimer disease

Lee, S.-H., Rezzonico, M. G., Friedman, B. A., Huntley, M. H., Meilandt, W. J., Pandey, S., Chen, Y.-J. J., Easton, A. E., Modrusan, Z. D., Hansen, D. V., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110158 · Cited by 76 · see citing works

Neuron Loss in Alzheimer’s Disease: Translation in Transgenic Mouse Models

Wirths, O., & Zampar, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218144 · Cited by 75 · see citing works

APP transgenic mice: their use and limitations

Balducci, C., & Forloni, G. (2011) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8141-7 · Cited by 79 · see citing works

Lost in translation: Inconvenient truths on the utility of mouse models in Alzheimer’s disease research

Granzotto, A., Vissel, B., & Sensi, S. L. (2024) · eLife · doi:10.7554/elife.90633 · Cited by 71 · see citing works

Synergistic toxicity between tau and amyloid drives neuronal dysfunction and neurodegeneration in transgenic C. elegans

Benbow, S. J., Strovas, T. J., Darvas, M., Saxton, A. D., & Kraemer, B. C. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz319 · Cited by 65 · see citing works

Alzheimer's Disease, Oestrogen and Mitochondria: an Ambiguous Relationship

Grimm, A., Lim, Y.-A., Mensah‐Nyagan, A. G., Götz, J., & Eckert, A. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8281-x · Cited by 62 · see citing works

Modeling Alzheimer’s disease: from past to future

Saraceno, C., Musardo, S., Marcello, E. E., Pelucchi, S., & Luca, M. D. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00077 · Cited by 61 · see citing works

Intracellular Calcium Dysregulation by the Alzheimer’s Disease-Linked Protein Presenilin 2

Galla, L., Redolfi, N., Pozzan, T., Pizzo, P., & Greotti, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030770 · Cited by 57 · see citing works

Selective degeneration of septal and hippocampal GABAergic neurons in a mouse model of amyloidosis and tauopathy

Loreth, D., Ozmen, L., Revel, F. G., Knoflach, F., Wetzel, P., Frotscher, M., Metzger, F., & Kretz, O. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.011 · Cited by 58 · see citing works

Proton and Phosphorus Magnetic Resonance Spectroscopy of a Mouse Model of Alzheimer's Disease

Mlynárik, V., Cacquevel, M., Sun-Reimer, L., Janssens, S., Cudalbu, C., Lei, H., Schneider, B. L., Aebischer, P., & Rolf Gruetter, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-112072 · Cited by 52 · see citing works

Disease-associated microglia in neurodegenerative diseases: Friend or foe?

Cheng, Y.-H., & Ho, M. S.-C. (2025) · PLoS Biology · doi:10.1371/journal.pbio.3003426 · Cited by 54 · see citing works

Human TAUP301L overexpression results in TAU hyperphosphorylation without neurofibrillary tangles in adult zebrafish brain

Coşacak, M. İ., Bhattarai, P., Bocova, L., Dzewas, T., Mashkaryan, V., Papadimitriou, C., Brandt, K., Hollak, H., Antos, C. L., & Kızıl, Ç. (2017) · Scientific Reports · doi:10.1038/s41598-017-13311-5 · Cited by 50 · see citing works

Brief update on different roles of tau in neurodegeneration

Ittner, A., Ke, Y. D., van Eersel, J., Gladbach, A., Götz, J., & Ittner, L. M. (2011) · IUBMB Life · doi:10.1002/iub.467 · Cited by 47 · see citing works

A subcutaneous cellular implant for passive immunization against amyloid-β reduces brain amyloid and tau pathologies

Lathuilière, A., Laversenne, V., Astolfo, A., Kopetzki, E., Jacobsen, H., Stampanoni, M., Bohrmann, B., Schneider, B. L., & Aebischer, P. (2016) · Brain · doi:10.1093/brain/aww036 · Cited by 46 · see citing works

Pseudophosphorylation of tau at S422 enhances SDS-stable dimer formation and impairs both anterograde and retrograde fast axonal transport

Tiernan, C. T., Combs, B., Cox, K. K., Morfini, G. A., Brady, S. T., Counts, S., & Kanaan, N. M. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.06.030 · Cited by 46 · see citing works

Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice

Köhler, C. N., Dinekov, M., & Götz, J. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2012.11.010 · Cited by 45 · see citing works

In vivo induction of membrane damage by β-amyloid peptide oligomers

Julien, C., Tomberlin, C., Roberts, C. M., Akram, A., Stein, G. H., Silverman, M. A., & Link, C. D. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0634-x · Cited by 39 · see citing works

Spatial memory deficiency early in 6xTg Alzheimer’s disease mouse model

Kang, S., Kim, J., & Chang, K.-A. (2021) · Scientific Reports · doi:10.1038/s41598-020-79344-5 · Cited by 39 · see citing works

High-Fat Diets in Animal Models of Alzheimer’s Disease: How Can Eating Too Much Fat Increase Alzheimer’s Disease Risk?

Valentin‐Escalera, J., Leclerc, M., & Calon, F. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-230118 · Cited by 35 · see citing works

Biological basis for amyloidogenesis in Alzheimer’S disease

Андреева, Т. В., Lukiw, W. J., & Rogaev, E. I. (2017) · Biochemistry (Moscow) · doi:10.1134/s0006297917020043 · Cited by 36 · see citing works

Relevance of transgenic mouse models for Alzheimer's disease

Tai, L. M., Weng, J. M., LaDu, M. J., & Brady, S. T. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.07.007 · Cited by 37 · see citing works

Neutral or Detrimental Effects of TREM2 Agonist Antibodies in Preclinical Models of Alzheimer’s Disease and Multiple Sclerosis

Etxeberria, A., Shen, Y.-A. A., Vito, S., Silverman, S. M., Imperio, J., Lalehzadeh, G., Soung, A. L., Du, C., Xie, L., Choy, M. K., et al. (2024) · The Journal of Neuroscience · doi:10.1523/jneurosci.2347-23.2024 · Cited by 34 · see citing works

Presenilin-2 and Calcium Handling: Molecules, Organelles, Cells and Brain Networks

Pizzo, P., Basso, E., Filadi, R., Greotti, E., Leparulo, A., Pendin, D., Redolfi, N., Rossini, M., Vajente, N., Pozzan, T., et al. (2020) · Cells · doi:10.3390/cells9102166 · Cited by 34 · see citing works

Spread of pathological human Tau from neurons to oligodendrocytes and loss of high-firing pyramidal neurons in aging mice

Viney, T. J., Sárkány, B., Ozdemir, A. T., Hartwich, K., Schweimer, J. V., Bannerman, D. M., & Somogyi, P. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111646 · Cited by 34 · see citing works

Dampened Slow Oscillation Connectivity Anticipates Amyloid Deposition in the PS2APP Mouse Model of Alzheimer’s Disease

Leparulo, A., Mahmud, M., Scremin, E., Pozzan, T., Vassanelli, S., & Fasolato, C. (2019) · Cells · doi:10.3390/cells9010054 · Cited by 31 · see citing works

Immunolesion‐induced loss of cholinergic projection neurones promotes β‐amyloidosis and tau hyperphosphorylation in the hippocampus of triple‐transgenic mice

Härtig, W., Saul, A., Kacza, J., Grosche, J., Goldhammer, S., Michalski, D., & Wirths, O. (2014) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12050 · Cited by 34 · see citing works

Chaperone-mediated autophagy and disease: Implications for cancer and neurodegeneration

Gómez‐Sintes, R., & Arias, E. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101025 · Cited by 29 · see citing works

The Accumulation of Tau in Postsynaptic Structures: A Common Feature in Multiple Neurodegenerative Diseases?

Teravskis, P. J., Ashe, K. H., & Liao, D. (2020) · The Neuroscientist · doi:10.1177/1073858420916696 · Cited by 28 · see citing works

Neurochemical dementia diagnostics in Alzheimer’s disease: where are we now and where are we going?

Lewczuk, P., & Kornhuber, J. (2011) · Expert Review of Proteomics · doi:10.1586/epr.11.37 · Cited by 28 · see citing works

PET Imaging in Animal Models of Alzheimer’s Disease

Chen, B., Marquez-Nostra, B. V., Belitzky, E., Toyonaga, T., Tong, J., Huang, Y. H., & Cai, Z. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.872509 · Cited by 27 · see citing works

Synaptic vulnerability to amyloid-β and tau pathologies differentially disrupts emotional and memory neural circuits

Capilla-López, M. D., Deprada-Fernandez, Á., Andrade‐Talavera, Y., Martínez‐Gallego, I., Coatl-Cuaya, H., Sotillo, P. S., Rodrı́guez-Álvarez, J., Moreno, A. R., Parra‐Damas, A., & Saura, C. A. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-02901-9 · Cited by 29 · see citing works

Amyloid-β plaque deposition measured using propagation-based X-ray phase contrast CT imaging

Astolfo, A., Lathuilière, A., Laversenne, V., Schneider, B. L., & Stampanoni, M. (2016) · Journal of Synchrotron Radiation · doi:10.1107/s1600577516004045 · Cited by 22 · see citing works

Sex differences of brain and their implications for personalized therapy

Rezzani, R., Franco, C., & Rodella, L. F. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.01.030 · Cited by 22 · see citing works

Enhanced dentate gyrus synaptic plasticity but reduced neurogenesis in a mouse model of amyloidosis

Poirier, R., Veltman, I., Pflimlin, M., Knoflach, F., & Metzger, F. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.06.014 · Cited by 20 · see citing works

Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau

Zampar, S., & Wirths, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105191 · Cited by 18 · see citing works

Alzheimer's disease models and functional genomics—How many needles are there in the haystack?

Götz, J., Matamales, M., Götz, N. N., Ittner, L. M., & Eckert, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00320 · Cited by 18 · see citing works

A Snapshot on the Current Status of Alzheimer’s Disease, Treatment Perspectives, in-Vitro and in-Vivo Research Studies and Future Opportunities

Tezel, G., Timur, S. S., Bozkurt, İ., Türkoğlu, Ö. F., Eroğlu, İ., Nemutlu, E., Öner, L., & Eroğlu, H. (2019) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.c19-00511 · Cited by 17 · see citing works

Chaperone-mediated autophagy regulates neuronal activity by sex-specific remodelling of the synaptic proteome

Khawaja, R. R., Griego, E., Lindenau, K. L., Salek, A. B., Gambardella, J., Scrivo, A., Monday, H. R., Bourdenx, M., Madero‐Pérez, J., Khan, Z. N., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-025-01771-1 · Cited by 16 · see citing works

What is the gold standard model for Alzheimer’s disease drug discovery and development?

Cacabelos, R., Carrera, I., Martínez-Iglesias, O. A., Cacabelos, N., & Naidoo, V. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1960502 · Cited by 15 · see citing works

Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases

Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000025 · Cited by 18 · see citing works

Biophysical studies of protein misfolding and aggregation in in vivo models of Alzheimer's and Parkinson's diseases – ERRATUM

Sinnige, T., Stroobants, K., Dobson, C. M., & Vendruscolo, M. (2020) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583520000104 · Cited by 15 · see citing works

Critical thinking of Alzheimer’s transgenic mouse model: current research and future perspective

Li, X., Quan, M., Wei, Y., Wang, W., Xu, L., Wang, Q., & Jia, J. (2023) · Science China Life Sciences · doi:10.1007/s11427-022-2357-x · Cited by 14 · see citing works

Drug Target Prioritization for Alzheimer's Disease Using Protein Interaction Network Analysis

Podder, A., Pandit, M., & Narayanan, L. (2018) · OMICS: A Journal of Integrative Biology · doi:10.1089/omi.2018.0131 · Cited by 14 · see citing works

The Earliest Tau Dysfunction in Alzheimer's Disease?

Voss, K., Koren, J., & Dickey, C. A. (2011) · American Journal Of Pathology · doi:10.1016/j.ajpath.2011.08.020 · Cited by 14 · see citing works

Analysis of the cholinergic pathology in the P301L tau transgenic pR5 model of tauopathy

Köhler, C. N., Bista, P., Götz, J., & Schröder, H. C. (2010) · Brain Research · doi:10.1016/j.brainres.2010.05.076 · Cited by 11 · see citing works

Anti-Aβ antibodies bound to neuritic plaques enhance microglia activity and mitigate tau pathology

Laversenne, V., Nazeeruddin, S., Källstig, E., Colin, P., Voize, C., & Schneider, B. L. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01069-3 · Cited by 10 · see citing works

Novel screening cascade identifies MKK4 as key kinase regulating Tau phosphorylation at Ser422

Grueninger, F., Bohrmann, B., Christensen, K., Graf, M. R., Roth, D., & Czech, C. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0890-6 · Cited by 9 · see citing works

A Human Embryonic Stem Cell Model of Aβ-Dependent Chronic Progressive Neurodegeneration

Ubina, T., Magallanes, M., Srivastava, S., Warden, C., Yee, J., & Salvaterra, P. M. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.01007 · Cited by 9 · see citing works

Unsupervised Co-Optimization of A Graph Neural Network and A Knowledge Graph Embedding Model to Prioritize Causal Genes for Alzheimer’s Disease

Prabhakar, V., & Liu, K. (2023) · Archives of Clinical and Biomedical Research · doi:10.26502/acbr.50170342 · Cited by 8 · see citing works

Limitations and Applications of Rodent Models in Tauopathy and Synucleinopathy Research

Szegvari, E., Holec, S. A. M., & Woerman, A. L. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70021 · Cited by 8 · see citing works

Tau and neurodegenerative disorders

Motoi, Y., Sahara, N., Kambe, T., & Hattori, N. (2010) · BioMolecular Concepts · doi:10.1515/bmc.2010.017 · Cited by 5 · see citing works

Alzheimer’s Disease: Insights from Genetic Mouse Models and Current Advances in Human IPSC-Derived Neurons

Harasta, A. E., & Ittner, L. M. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-57193-5_1 · Cited by 5 · see citing works

Long noncoding RNA MEG3 activates neuronal necroptosis in Alzheimer’s diseasePreprint

Balusu, S., Horré, K., Thrupp, N., Snellinx, A., Serneels, L., Chrysidou, I., Arranz, A. M., Sierksma, A. S. R., Simrén, J., Karikari, T. K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.18.480849 · Cited by 5 · see citing works

Microglia-mediated protection against Alzheimer’s disease pathology and detrimental effects in white matter revealed by Ptpn6 deletion

Etxeberría, A., Lee, S.-H., Kuhn, J., Callow, M. G., Novikova, G., Fortin, J., Choy, M. K., Xie, L., Imperio, J., Vito, S., et al. (2026) · Neuron · doi:10.1016/j.neuron.2026.02.023 · Cited by 4 · see citing works

Currently Available Biomarkers and Strategies for the Validation of Novel Candidates for Neurochemical Dementia Diagnostics in Alzheimer’s Disease and Mild Cognitive Impairment

Lewczuk, P. (2014) · Advances in Geriatrics · doi:10.1155/2014/891780 · Cited by 4 · see citing works

Review of Alzheimer’s Disease’s Animal Model with it’s Pathophysiology and Drug Discovery

Pal, T., & Das, M. (2024) · Asian Journal of Research in Pharmaceutical Sciences · doi:10.52711/2231-5659.2024.00006 · Cited by 4 · see citing works

Animal models for Alzheimer's disease – the industry perspective

Czech, C., & Grueninger, F. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.07.001 · Cited by 2 · see citing works

Mechanisms of the Pathogenesis of Alzheimer’s Disease: The Role of the Basal Forebrain

Kitchigina, V. F., Popova, I. Y., & Shubina, L. (2025) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-025-01784-1 · Cited by 2 · see citing works

Gene Delivery and Gene Therapy for Alzheimer’s Disease

Woodbury, M. E., Kiyota, T., & Ikezu, T. (2015) · Neuromethods · doi:10.1007/978-1-4939-2306-9_4 · Cited by 2 · see citing works

Transgenic Animal Models of Proteinopathies

Sahara, N., Melrose, H. L., D’Alton, S., & Lewis, J. M. (2011) · doi:10.1002/9781444341256.ch7 · Cited by 2 · see citing works

Genetically Engineered Mouse Models for Alzheimer Disease and Frontotemporal Dementia

Chiu, Y., Xia, S., Qiao, H., & Zhao, Z. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.11.006 · Cited by 3 · see citing works

Prévenir la progression de la pathologie Tau par immunothérapie passive

Ozmen, L., & Collin, L. (2015) · médecine/sciences · doi:10.1051/medsci/20153102006 · Cited by 1 · see citing works

Molecular Mechanisms of Synaptic Plasticity and Memory and Their Dysfunction in Alzheimer's Disease ☆

Stephens, G. S., You, J. C., Fu, C.-H., & Chin, J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809324-5.21126-7 · Cited by 1 · see citing works

A human embryonic stem cell model of Aβ-dependent chronic progressive neurodegenerationPreprint

Ubina, T., Magallanes, M., Srivastava, S., Warden, C., Yee, J., & Salvaterra, P. M. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/419978 · Cited by 1 · see citing works

Deregulation of oxidative phosphorylation system and energy homeostasis in Alzheimer's disease

Rhein, V. F. (2009) · edoc (University of Basel) · doi:10.5451/unibas-005042311

A new paradigm for testing AD drugs – neuroimaging biomarkers as surrogate outcomes homologous in animals and humans

Marizzoni, M., Forloni, G., & Frisoni, G. B. (2013) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.09.003

Avaliação da memória e das características neuropatológicas da doença de Alzheimer, em um modelo experimental, após estimulação em ambiente enriquecido.

Balthazar, J. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2013.tde-26092013-111146

Amyloid β accelerates phosphorylation of tau and neurofibrillary tangle formation in an amyloid precursor protein and tau double‐transgenic mouse model

Seino, Y., Kawarabayashi, T., Wakasaya, Y., Watanabe, M., Takamura, A., Yamamoto‐Watanabe, Y., Kurata, T., Abe, K., Ikeda, M., Westaway, D. A., et al. (2010) · Journal of Neuroscience Research · doi:10.1002/jnr.22516 · Cited by 31 · see citing works

Characterization of a double (amyloid precursor protein-tau) transgenic: Tau phosphorylation and aggregation

Pérez, M., Ribé, E. M., Rubio, A., Lim, F., Morán, M. A., Gómez‐Ramos, P., Ferrer, I., Isla, M. T. G., & Ávila, J. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.09.029 · Cited by 83 · see citing works

Influence of different types of amyloid β pathologies on tau pathology in Alzheimer´s disease in different APP-TAU double transgenic mouse models

Hipp, S. A. (2017) · OPen Access Repositorium der Universität Ulm (OPARU) (Ulm University) · doi:10.18725/oparu-9113

Characterization of a Mouse Model of Alzheimer’s Disease Expressing Aβ4-42 and Human Mutant Tau

Zampar, S., & Wirths, O. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22105191 · Cited by 18 · see citing works

Enhanced accumulation of tau in doubly transgenic mice expressing mutant βAPP and presenilin-1

Samura, E., Shoji, M., Kawarabayashi, T., Sasaki, A., Matsubara, E., Murakami, T., Wuhua, X., Tamura, S., Ikeda, M., Ishiguro, K., et al. (2006) · Brain Research · doi:10.1016/j.brainres.2005.12.134 · Cited by 33 · see citing works